Key clinical point: The presence of sarcopenic obesity (SO) increases the risk for severe postoperative complications and worse survival outcomes in patients who have undergone gastrectomy for gastric cancer.
Major finding: SO was associated with an increased risk for serious Clavien-Dindo complications grade >IIIb/IV (odds ratio 2.82; P = .028) and worse overall survival (adjusted hazard ratio 0.45; P = .026) after gastrectomy.
Study details: This single-center retrospective study included 190 patients with gastric cancer who had undergone curative-intent gastrectomy, of which 40 patients had SO.
Disclosures: This study did not report the source of funding. The authors declared no conflicts of interest.
Source: Juez LD et al. Impact of sarcopenic obesity on long-term cancer outcomes and postoperative complications after gastrectomy for gastric cancer. J Gastrointest Surg. 2022 (Nov 2). Doi: 10.1007/s11605-022-05492-w